Clinical Trial: An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to determine the effect of an approved medication for adults for an investigational use in pediatric patients 3 months to 17 years for the treatment of complicated intra-abdominal infections or acute pelvic infections.

Condition Treatment or Intervention Phase
Infections
Pelvic Infections
 
Phase II
Phase III

MedlinePlus consumer health information 

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Safety/Efficacy Study

Official Title: An Open Label Study Using an Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections

Eligibility

Ages Eligible for Study:  3 Months   -   17 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Immune problems
  • Kidney problems

Location Information


Pennsylvania
      Call for Information, Horsham,  Pennsylvania,  19044,  United States

More Information

Study ID Numbers:  2004_062
Record last reviewed:  September 2004
Last Updated:  October 13, 2004
Record first received:  September 21, 2004
ClinicalTrials.gov Identifier:  NCT00092170
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources